HCPCS Level IIdrugActive
J2356
Inj tezepelumab-ekko, 1mg
BETOS: O1E
Effective: 2022-07-01
Referenced in 1 policies
Description
Injection, tezepelumab-ekko, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tezspire
Manufacturer
Amgen Inc
HCPCS Dosage
1 MG
Billing Units
210.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.